Cytokine induced tumor killer cell therapy (Shanghai Zhongke Yingda Biotechnology)
与树突状细胞共培养的细胞因子诱导的杀伤细胞（中科英达生物技术）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameCytokine induced tumor killer cell therapy (Shanghai Zhongke Yingda Biotechnology)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesShanghai Zhongke Yingda Biotechnology Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesShanghai Zhongke Yingda Biotechnology Co Ltd
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A